Department of Cardiology, SKIMS, Soura, Srinagar, Jammu & Kashmir, India.
Department of Medicine, SKIMS, Soura, Srinagar, Jammu & Kashmir, India.
Europace. 2018 Aug 1;20(8):1318-1323. doi: 10.1093/europace/eux215.
This study was conducted to compare the safety and efficacy of microwire assisted technique with contrast venography guided axillary venipuncture in patients undergoing cardiovascular implantable electronic device (CIED) implantation.
This prospective randomized study included 212 consecutive adult patients undergoing CIED implantation at our institute between 2013 and 2015. Patients were randomized to either venography guided technique (Group I; n = 105) or microwire assisted technique (Group II; n = 107) for axillary venipuncture. In Group I axillary venogram was used as a roadmap for guiding the puncture. In Group II, a 0.014 inch hydrophilic coronary guidewire ('microwire') was introduced through the ipsilateral antecubital vein and puncture needle was aimed to hit the microwire over the first or second rib. Outcome measures including technical success rates; number of attempts to successful puncture; puncture duration; fluoroscopy times and adverse events were compared in the two groups. Overall success rates were similar in both groups (97.4% in Group I and 100% in Group II, P = 0.061). We demonstrated significantly higher first attempt success rates; shorter puncture durations and fluoroscopy times; and lower number of attempts to successful puncture with microwire assisted technique (89.3% vs. 65.6%; 36.7 ± 23.1 s vs. 67.8 ± 44.9 s; 62.4 ± 35.3 s vs. 118.9 ± 63.2 s; and 1.21 ± 0.82 vs. 2.16 ± 1.54 respectively, P < 0.001). Adverse event rates were significantly lower with microwire assisted technique (0.9% vs. 8.6%, P = 0.009).
Microwire assisted technique is a simple, quicker, safer and more efficacious alternative to contrast venography guided axillary venipuncture.
本研究旨在比较在接受心血管植入式电子设备(CIED)植入的患者中,微丝辅助技术与对比静脉造影引导腋静脉穿刺的安全性和有效性。
这项前瞻性随机研究纳入了 2013 年至 2015 年在我院接受 CIED 植入的 212 例连续成年患者。患者被随机分为静脉造影引导技术组(I 组,n=105)或微丝辅助技术组(II 组,n=107)进行腋静脉穿刺。在 I 组中,腋静脉造影用作引导穿刺的路线图。在 II 组中,将 0.014 英寸亲水冠状动脉导丝(“微丝”)引入对侧肘前静脉,并将穿刺针瞄准在第一或第二肋骨上方命中微丝。比较两组的技术成功率;成功穿刺的尝试次数;穿刺持续时间;透视时间和不良事件。两组的总体成功率相似(I 组为 97.4%,II 组为 100%,P=0.061)。我们证明微丝辅助技术具有更高的首次尝试成功率;更短的穿刺持续时间和透视时间;以及更少的尝试次数以达到成功穿刺(89.3%比 65.6%;36.7±23.1s 比 67.8±44.9s;62.4±35.3s 比 118.9±63.2s;1.21±0.82 比 2.16±1.54,P<0.001)。微丝辅助技术的不良事件发生率明显较低(0.9%比 8.6%,P=0.009)。
微丝辅助技术是一种简单、快速、安全且更有效的替代对比静脉造影引导腋静脉穿刺的方法。